These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26918035)

  • 101. Prostate Cancer Prevention: Concepts and Clinical Trials.
    Hamilton Z; Parsons JK
    Curr Urol Rep; 2016 Apr; 17(4):35. PubMed ID: 26957512
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial.
    Cooper C; Harvey NC; Bishop NJ; Kennedy S; Papageorghiou AT; Schoenmakers I; Fraser R; Gandhi SV; Carr A; D'Angelo S; Crozier SR; Moon RJ; Arden NK; Dennison EM; Godfrey KM; Inskip HM; Prentice A; Mughal MZ; Eastell R; Reid DM; Javaid MK;
    Lancet Diabetes Endocrinol; 2016 May; 4(5):393-402. PubMed ID: 26944421
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Is there a role for vitamin D in human reproduction?
    Nandi A; Sinha N; Ong E; Sonmez H; Poretsky L
    Horm Mol Biol Clin Investig; 2016 Jan; 25(1):15-28. PubMed ID: 26943610
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Vitamin D supplementation in inflammatory bowel disease: the role of dosage and patient compliance.
    Kojecky V; Adamikova A; Klimek P
    Bratisl Lek Listy; 2016; 117(3):148-51. PubMed ID: 26925744
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Effect of high-dose vitamin D supplementation on bone density in youth with osteogenesis imperfecta: A randomized controlled trial.
    Plante L; Veilleux LN; Glorieux FH; Weiler H; Rauch F
    Bone; 2016 May; 86():36-42. PubMed ID: 26924265
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy.
    de la Taille A; Martínez-Piñeiro L; Cabri P; Houchard A; Schalken J;
    BJU Int; 2017 Jan; 119(1):74-81. PubMed ID: 26919403
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Diet and risk of breast cancer.
    Kotepui M
    Contemp Oncol (Pozn); 2016; 20(1):13-9. PubMed ID: 27095934
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Association of vitamin D receptor variants with clinical parameters in prostate cancer.
    Nunes SB; de Matos Oliveira F; Neves AF; Araujo GR; Marangoni K; Goulart LR; Araújo TG
    Springerplus; 2016; 5():364. PubMed ID: 27066374
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Calcium and 1,25-dihydroxyvitamin D3 modulate genes of immune and inflammatory pathways in the human colon: a human crossover trial.
    Protiva P; Pendyala S; Nelson C; Augenlicht LH; Lipkin M; Holt PR
    Am J Clin Nutr; 2016 May; 103(5):1224-31. PubMed ID: 27009752
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer.
    Evans CP; Higano CS; Keane T; Andriole G; Saad F; Iversen P; Miller K; Kim CS; Kimura G; Armstrong AJ; Sternberg CN; Loriot Y; de Bono J; Noonberg SB; Mansbach H; Bhattacharya S; Perabo F; Beer TM; Tombal B
    Eur Urol; 2016 Oct; 70(4):675-683. PubMed ID: 27006332
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Breast cancer survival among young women: a review of the role of modifiable lifestyle factors.
    Brenner DR; Brockton NT; Kotsopoulos J; Cotterchio M; Boucher BA; Courneya KS; Knight JA; Olivotto IA; Quan ML; Friedenreich CM
    Cancer Causes Control; 2016 Apr; 27(4):459-72. PubMed ID: 26970739
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Is Vitamin D Inadequacy in Early Life an Instance of the "Barker Hypothesis"?
    Heaney RP
    Nutr Today; 2016 Jan; 51(1):14-17. PubMed ID: 26941468
    [No Abstract]   [Full Text] [Related]  

  • 113. Stroke related to androgen deprivation therapy for prostate cancer: a meta-analysis and systematic review.
    Meng F; Zhu S; Zhao J; Vados L; Wang L; Zhao Y; Zhao D; Niu Y
    BMC Cancer; 2016 Mar; 16():180. PubMed ID: 26940836
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use.
    Sarre S; Määttänen L; Tammela TL; Auvinen A; Murtola TJ
    Scand J Urol; 2016 Aug; 50(4):267-73. PubMed ID: 26927237
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Prevalence and correlates of vitamin D deficiency in adults after traumatic brain injury.
    Jamall OA; Feeney C; Zaw-Linn J; Malik A; Niemi ME; Tenorio-Jimenez C; Ham TE; Jilka SR; Jenkins PO; Scott G; Li LM; Gorgoraptis N; Baxter D; Sharp DJ; Goldstone AP
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):636-44. PubMed ID: 26921561
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Vitamin D and patients with palliative cancer.
    Björkhem-Bergman L; Bergman P
    BMJ Support Palliat Care; 2016 Sep; 6(3):287-91. PubMed ID: 27084421
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Fat-Soluble Vitamins: Clinical Indications and Current Challenges for Chromatographic Measurement.
    Albahrani AA; Greaves RF
    Clin Biochem Rev; 2016 Feb; 37(1):27-47. PubMed ID: 27057076
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Markers of Vitamin D Exposure and Esophageal Cancer Risk: A Systematic Review and Meta-analysis.
    Zgaga L; O'Sullivan F; Cantwell MM; Murray LJ; Thota PN; Coleman HG
    Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):877-86. PubMed ID: 27030602
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Chemotherapy following radium-223 dichloride treatment in ALSYMPCA.
    Sartor O; Hoskin P; Coleman RE; Nilsson S; Vogelzang NJ; Petrenciuc O; Staudacher K; Thuresson M; Parker C
    Prostate; 2016 Jul; 76(10):905-16. PubMed ID: 27004570
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Clinical Effect of Switching from a Luteinizing Hormone-Releasing Hormone Agonist to an Antagonist in Patients with Castration-Resistant Prostate Cancer and Serum Testosterone Level ≥ 20 ng/dl.
    Soga N; Kageyama T; Ogura Y; Yamada T; Hayashi N
    Curr Urol; 2016 Feb; 9(1):31-5. PubMed ID: 26989369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.